Olga A. Balabon - Concepedia

Author

Olga A. Balabon

Also Known As

Balabon, Olga, Balabon, Olga A., Olga A. Balabon, Olga Balabon

Publications

144

Citations

H-Index

Concepts

All Affiliations

Olga A. Balabon is an author at GlaxoSmithKline (Spain) specializing in drug discovery, medicinal chemistry, and drug resistance.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	91
2	Natural Sciences	2	2	91
3	Biochemistry	2	2	91
4	Pharmacology	2	2	91
5	Microbiology	1	1	41

Olga A. Balabon

Publications

137

Citations

H-Index

Page 1

	Year	Citations
Searching for New Leads for Tuberculosis: Design, Synthesis, and Biological Evaluation of Novel 2-Quinolin-4-yloxyacetamides Eleni Pitta, Maciej K. Rogacki, Olga A. Balabon, Journal of Medicinal Chemistry Combinatorial ChemistryBioorganic ChemistryNew SeriesPharmaceutical ChemistryDrug Resistance	2016	50
Identification and Profiling of Hydantoins—A Novel Class of Potent Antimycobacterial DprE1 Inhibitors Maciej K. Rogacki, Eleni Pitta, Olga A. Balabon, Journal of Medicinal Chemistry Antimicrobial ChemotherapyPharmaceutical ChemistryDrug ResistanceMedicinal ChemistryMycobacterium Tuberculosis	2018	41
Optimization of Hydantoins as Potent Antimycobacterial Decaprenylphosphoryl-β-<scp>d</scp>-Ribose Oxidase (DprE1) Inhibitors Olga A. Balabon, Eleni Pitta, Maciej K. Rogacki, Journal of Medicinal Chemistry	2020	25
Synthesis and Properties of Polyfunctional Cyclic β‐Alkoxy‐α,β‐Unsaturated Ketones Based on 4‐Methylene‐1,3‐dioxolanes Igor I. Gerus, Olga A. Balabon, Sergiy V. Pazenok, European Journal of Organic Chemistry	2018	11
Differential characterization using readily accessible NMR experiments of novel N- and O-alkylated quinolin-4-ol, 1,5-naphthyridin-4-ol and quinazolin-4-ol derivatives with antimycobacterial activity Eleni Pitta, Olga A. Balabon, Maciej K. Rogacki, European Journal of Medicinal Chemistry	2016	10

Page 1